Evidence map›Paper›PMID 22266381›Full record

ArticleClinical chemistry2012

Four-color alternating-laser excitation single-molecule fluorescence spectroscopy for next-generation biodetection assays.

Seok W Yim, Taiho Kim, Ted A Laurence, Steve Partono, Dongsik Kim, Younggyu Kim, Shimon Weiss, Armin Reitmair

Open access · bronzeAbstract read
In one paragraph

Article in Clinical chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Silicon photon-counting avalanche diodes for single-molecule fluorescence spectroscopy.IEEE journal of selected topics in quantum electronics : a publication of the IEEE Lasers and Electro-optics Society · 2014
    Article
  16. Non-Coding RNAs: Functional Aspects and Diagnostic Utility in Oncology.International journal of molecular sciences · 2013
    Article
  17. Development of new photon-counting detectors for single-molecule fluorescence microscopy.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2013
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Seok W YimNesher Technologies, Inc., Los Angeles, CA 90057, USA.
Taiho Kim
Ted A Laurence
Steve Partono
Dongsik Kim
Younggyu Kim
Shimon Weiss
Armin Reitmair
Nesher Technologies (United States) · USUniversity of California, Los Angeles · US

Funding

Rapid, Highly Multiplexed and Sensitive Blood Test for Drug-resistant BacteriaR43AI078635 · NIAID · NESHER TECHNOLOGIES, INC. · PI KIM, TAIHO, REITMAIR, ARMIN H · 2009 to 2010
$598k
Compact ALEX-based Reader for Highly Multiplexed Single Biomolecule DetectionR43GM085962 · NIGMS · NESHER TECHNOLOGIES, INC. · PI KIM, TAIHO · 2009 to 2010
$520k
Multiplexed Protein & miRNA Biomarker-based Next-gen Test for Alzheimers DiseaseR43AG044951 · NIA · NESHER TECHNOLOGIES, INC. · PI KIM, TAIHO, REITMAIR, ARMIN H · 2013 to 2014
$463k
Highly Multiplexed Sensitive Specific & Automated Test for Neurogenetic DisordersR41NS060231 · NINDS · NESHER TECHNOLOGIES, INC. · PI REITMAIR, ARMIN H · 2007 to 2008
$415k
Real-time Single-Molecule Analysis for Transient Molec. Complex CharacterizationR43RR026190 · NCRR · NESHER TECHNOLOGIES, INC. · PI KIM, TAIHO, REITMAIR, ARMIN H · 2009 to 2009
$190k
Multiplexed Ultrasensitive Mix-and-Read Tumor Marker Quantification AssaysR41CA121853 · NCI · NESHER TECHNOLOGIES, INC. · PI REITMAIR, ARMIN H · 2006 to 2006
$100k
NCI NIH HHS R41 CA121853NCI NIH HHS R41CA121853NCRR NIH HHS 1R43RR026190NCRR NIH HHS R43 RR026190NIAID NIH HHS R43 AI078635NIAID NIH HHS R43AI078635NIA NIH HHS R43 AG044951NIGMS NIH HHS R43 GM085962NIGMS NIH HHS R43GM085962NINDS NIH HHS R41 NS060231
6 · The paper itself

Abstract

backgroundSingle-molecule detection (SMD) technologies are well suited for clinical diagnostic applications by offering the prospect of minimizing precious patient sample requirements while maximizing clinical information content. Not yet available, however, is a universal SMD-based platform technology that permits multiplexed detection of both nucleic acid and protein targets and that is suitable for automation and integration into the clinical laboratory work flow.

methodsWe have used a sensitive, specific, quantitative, and cost-effective homogeneous SMD method that has high single-well multiplexing potential and uses alternating-laser excitation (ALEX) fluorescence-aided molecule sorting extended to 4 colors (4c-ALEX). Recognition molecules are tagged with different-color fluorescence dyes, and coincident confocal detection of ≥2 colors constitutes a positive target-detection event. The virtual exclusion of the majority of sources of background noise eliminates washing steps. Sorting molecules with multidimensional probe stoichiometries (S) and single-molecule fluorescence resonance energy transfer efficiencies (E) allows differentiation of numerous targets simultaneously.

resultsWe show detection, differentiation, and quantification-in a single well-of (a) 25 different fluorescently labeled DNAs; (b) 8 bacterial genetic markers, including 3 antibiotic drug-resistance determinants found in 11 septicemia-causing Staphylococcus and Enterococcus strains; and (c) 6 tumor markers present in blood.

conclusionsThe results demonstrate assay utility for clinical molecular diagnostic applications by means of multiplexed detection of nucleic acids and proteins and suggest potential uses for early diagnosis of cancer and infectious and other diseases, as well as for personalized medicine. Future integration of additional technology components to minimize preanalytical sample manipulation while maximizing throughput should allow development of a user-friendly ("sample in, answer out") point-of-care platform for next-generation medical diagnostic tests that offer considerable savings in costs and patient sample.

Indexed as

Genetic MarkersBiological AssayBiomarkers, TumorDNADNA, BacterialDrug Resistance, BacterialEnterococcusFluorescence Resonance Energy TransferFluorescent DyesGenes, BacterialHumansLasersSensitivity and SpecificityStaphylococcusBiomarkers, TumorDNADNA, BacterialFluorescent DyesGenetic Markers

Identifiers

PMID22266381
PMCPMC5742282
OpenAlexW2100912256

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.